Lichen Planus (LP) is a chronic, immunologically mediated mucocutaneous disease that can affect mucosal surfaces, including those that line the oral cavity. It may affect the skin (cutaneous lichen planus), oral cavity (oral lichen planus), genitalia (penile or vulvar lichen planus), scalp (lichen planopilaris), nails, or oesophagus. Oral LP may be present in several forms, appearing alone or in combination, namely as Reticular, Atrophic/erosive, and Plaque-like oral LP.
Between 50 and 70% of patients show symptoms involving “mucous membranes”—the moist pink skin that lines the inside of the mouth, vagina, and oesophagus.
DelveInsight's "Lichen Planus Market" reports deliver an in-depth understanding of the historical and forecasted epidemiology, the pipeline therapies, as well as the market size, shares, and trends analysis in the seven major markets (7MM).
Geographies Covered
The report analyses the Lichen Planus Market trends and developments in the seven major markets (i.e. the United States, Germany, France, Italy, Spain, the United Kingdom, and Japan.
Lichen Planus - Key Epidemiological Insights
- According to the NORD, Lichen Planus occurs in less than 1% of the world’s population. Additionally, cutaneous Lichen Planus occurs at similar frequencies in men and women, but women are somewhat more likely to develop oral Lichen Planus or lichen planopilaris, and the majority of LP develops between 30 and 60 years of age but can affect older and younger individuals as well.
- As per the Human Phenotype Ontology (HPO) Database, 80–99% of LPP patients develop alopecia, hyperkeratosis, lichenification, and papule, while 30–79% of people develop abnormal fingernail morphology.
The market analysis section of the report helps to understand the current and forecasted Lichen Planus Market Trends and Growth by evaluating the impact of current therapies on the market, unmet needs, drivers, and barriers.
The report gives complete detail of Lichen Planus Market Size and Shares by assessing the marketed drug and late-stage pipeline therapy and evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Lichen Planus Epidemiology Forecast
The epidemiology section covers detailed insights about the patient pool for every seven major countries. It helps to recognize the causes of current and forecasted Lichen Planus Epidemiology Trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends.
Lichen Planus Epidemiology Segmentation
- Total Prevalent Population of Lichen Planus
- Type-specific Prevalent Population of Lichen Planus
- Diagnosed and Treatable Cases of Lichen Planus
- Gender-specific Prevalent Population of Lichen Planus
Currently, there are approx. 6+ key companies which are developing the therapies for Lichen Planus. AFYX Therapeutics has its Lichen Planus drug candidates in the most advanced, i.e., Phase III stage of development.
Lichen Planus Therapeutics Insights
Some of the key companies in the Lichen Planus Market include:
• Novartis
• Amgen
• Kiniksa Pharmaceuticals
• AFYX Therapeutics
• Regeneus
And many others
Lichen Planus Therapies covered in the report include:
• Rivelin-CLO: AFYX Therapeutics
And others
Report Assessment
- Unmet Needs
- Market Attractiveness
- Current Treatment Practices
- Market Drivers
- Market Barriers
- Pipeline Product
Table of Content
1. Key Insights
2. Executive Summary
3. Lichen Planus Competitive Intelligence Analysis
4. Lichen Planus Market Overview at a Glance
5. Lichen Planus Disease Background and Overview
6. Lichen Planus Patient Journey
7. Lichen Planus Epidemiology and Patient Population
8. Lichen Planus Treatment Algorithm, Current Treatment, and Medical Practices
9. Lichen Planus Unmet Needs
10. Key Endpoints of Lichen Planus Treatment
11. Lichen Planus Marketed Products
12. Lichen Planus Emerging Therapies
13. Lichen Planus Seven Major Market Analysis
14. Attribute Analysis
15. Lichen Planus Market Outlook (7 major markets)
16. Lichen Planus Access and Reimbursement Overview
17. KOL Views on the Lichen Planus Market.
18. Lichen Planus Market Drivers
19. Lichen Planus Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
For more details, visit: Lichen Planus Market Trends